Back

Percutaneous left atrial appendage closure and conservative antithrombotic treatment in patients with atrial fibrillation and contraindication to oral anticoagulation: a 5-year follow-up study

2 September 2019 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 4 - Non-coronary cardiac intervention Left Atrial Appendage (LAA) Closure ESC Premium Access ESC Congress 2019

About the speaker

Photo
Mr Jussi-Pekka Johannes Pouru

Turku University Hospital, Turku (Finland)

15 More presentations in this session

Presentation thumbnail
Doctor M. Johnsen (Oslo, NO)
Abstract Slides
Presentation thumbnail
Doctor P. Seppelt (Frankfurt, DE)
Abstract
Presentation thumbnail
Mr M. Alsaad (Detmold, DE)
Abstract
Presentation thumbnail
Doctor Z. Ostojic (Zagreb, HR)
Abstract Slides
Presentation thumbnail
Assistant Professor B. Al-Kassou (Bonn, DE)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 4 - Non-coronary cardiac intervention

The Event

Event poster

ESC Congress 2019

2 September 2019 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Non valvular atrial fibrillation, contraindication to anticoagulation or antiplatelet therapy and heart team approach: a single centre experience
2 September 2019
thumbnail
Congress Presentation
One year outcome and analysis of peri-device leak of left atrial appendage occlusion devices
27 August 2021
thumbnail
Congress Presentation
Oral anti-coagulants in fragile patients with percutaneous endoscopic gastrostomy and atrial fibrillation: the (ORIGAMI) study
29 June 2021
thumbnail
Congress Presentation
Prediction of low left atrial appendage velocity from echocardiographic left atrial function parameters in patients with atrial fibrillation undergoing catheter ablation.
10 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources